Healthcare -
Biotechnology - NASDAQ - US
$ 1.5
-0.662 %
$ 60.4 M
Market Cap
-1.22
P/E
IKNA - COST OF REVENUE
Cost of Revenue IKNA - Ikena Oncology, Inc.
1.02 M
LAST VALUE
-85.29%
2 YEAR CAGR
-51.75%
5 YEAR CAGR
0.00%
10 YEAR CAGR